21 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated
S-3
EX-5.1
CGTX
Cognition Therapeutics Inc
23 Dec 22
Shelf registration
4:16pm
. In rendering this opinion and giving this consent, we do not admit that we are an “expert” within the meaning of the Securities Act.
Very truly yours,
Troutman Pepper Hamilton Sanders LLP
-5-
DEF 14A
le7a b3el
25 Apr 22
Definitive proxy
5:28pm
S-8
EX-5.1
aanbx8qeg9s3 shrd
30 Mar 22
Registration of securities for employees
8:37am
8-K
2o6by03mof3m33ee3lt
3 Nov 21
Departure of Directors or Certain Officers
4:25pm
S-8
EX-5.1
ykn7wkmp4zf6gfif4
2 Nov 21
Registration of securities for employees
4:51pm
8-K
EX-3.2
2183v 17zqeendydr7xm
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
torbhka1nj i6fxqkiv
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1/A
EX-3.8
vc3jzg
29 Jul 21
IPO registration (amended)
4:45pm
S-1/A
EX-10.1
zphoxpmqpdna1k9
29 Jul 21
IPO registration (amended)
4:45pm
CORRESP
14gv52h7 8qz
29 Jul 21
Correspondence with SEC
12:00am
S-1
tm0bg6hsm7074
19 Jul 21
IPO registration
7:02am
DRS/A
04x34u26lg
23 Jun 21
Draft registration statement (amended)
12:00am